Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Armbruster

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Antimicrobial Chemotherapy|October 1, 2004
Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12Christine Armbruster, Gabriela M Stiegler, Brigitta A Vcelar, et al.
AIDS (London, England)|October 9, 2002
Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluationGabriela Stiegler, Christine Armbruster, Brigitta Vcelar, et al.
Contemporary Clinical Trials|May 1, 2021
The Pharmacist Discharge Care (PHARM-DC) study: A multicenter RCT of pharmacist-directed transitional care to reduce post-hospitalization utilizationJoshua M Pevnick, Michelle S Keller, Korey A Kennelty, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Antimicrobial Chemotherapy|October 1, 2004
Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12Christine Armbruster, Gabriela M Stiegler, Brigitta A Vcelar, et al.
AIDS (London, England)|October 9, 2002
Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluationGabriela Stiegler, Christine Armbruster, Brigitta Vcelar, et al.
Contemporary Clinical Trials|May 1, 2021
The Pharmacist Discharge Care (PHARM-DC) study: A multicenter RCT of pharmacist-directed transitional care to reduce post-hospitalization utilizationJoshua M Pevnick, Michelle S Keller, Korey A Kennelty, et al.
Pageof 2